Supernus Pharmaceuticals, Inc.

Pharmaceutical company · Rockville, Maryland, United States · Nasdaq: SUPN

Supernus Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Rockville, Maryland, United States. Its shares trade on Nasdaq under the ticker SUPN. The US FDA lists 1 drug manufacturing or testing site registered to the company. It has reported private securities offerings to the US SEC, most recently $30 million sold in a notice filed in 2012.

Profile compiled from public records. Is this your company? Request a correction or update

Supernus Pharmaceuticals at a glance

Typepharmaceutical company
HeadquartersRockville, Maryland, United States
Stock listingNasdaq: SUPN
SEC industryPharmaceutical Preparations
FDA-registered sites1
SEC CIK1356576

What does Supernus Pharmaceuticals do?

Operations at its FDA-registered drug sites

Analysis

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $30 million sold (2012).

Where is Supernus Pharmaceuticals located?

Headquarters: Rockville, Maryland, United States

  • Rockville, MarylandSupernus Pharmaceuticals Inc · FDA drug site

Frequently asked questions about Supernus Pharmaceuticals

Where is Supernus Pharmaceuticals headquartered?

Supernus Pharmaceuticals, Inc. is headquartered in Rockville, Maryland, United States.

What does Supernus Pharmaceuticals do?

Supernus Pharmaceuticals, Inc. is a pharmaceutical company. Its FDA-registered drug sites are registered for analysis. Its SEC industry classification is Pharmaceutical Preparations.

Is Supernus Pharmaceuticals a public company?

Yes. Supernus Pharmaceuticals, Inc. trades on Nasdaq under the ticker SUPN.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.